| Literature DB >> 24275377 |
Jinn-Ming Wang1, Hwee-Kheng Lim2.
Abstract
OBJECTIVES: To describe clinical, laboratory, microbiological features, and outcomes of necrotizing fasciitis.Entities:
Keywords: Antibiotics; Comorbidity; Debridement; Necrotizing fasciitis
Mesh:
Year: 2013 PMID: 24275377 PMCID: PMC9427441 DOI: 10.1016/j.bjid.2013.08.003
Source DB: PubMed Journal: Braz J Infect Dis ISSN: 1413-8670 Impact factor: 3.257
Clinical features of the 115 necrotizing fasciitis patients.
| Clinical features | No. of patients (% of total) |
|---|---|
| Local swelling/erythema | 92 (80%) |
| Fever | 87 (76%) |
| Pain/tenderness | 84 (73%) |
| Tachycardia | 43 (37%) |
| Shortness of breath | 32 (28%) |
| Shock | 30 (26%) |
| Bullous lesion | 25 (22%) |
| Consciousness change | 7 (6%) |
| Crepitus | 7 (6%) |
Anatomical sites involved with necrotizing fasciitis.
| Anatomical location | Number of cases (%) |
|---|---|
| 4 (3%) | |
| 15 (13%) | |
| Right | 8 (7%) |
| Left | 7 (6%) |
| 70 (61%) | |
| Right | 28 (24%) |
| Left | 38 (33%) |
| Bilateral | 4 (3%) |
| 11 (10%) | |
| 15 (13%) | |
Microorgansims isolated in patients with necrotizing fasciitis.
| Microorganisms | Total ( | Survival ( | Nonsurvival ( | Mortality rate of pathogen (%) |
|---|---|---|---|---|
| 60 (52.2%) | 49 (53.8%) | 11 (45.8%) | 18.3% | |
| MRSA | 13 (11.3%) | 10 (11%) | 3 (12.5%) | 23% |
| MSSA | 12 (10.4%) | 11 (12.1%) | 1 (4.2%) | 8.3% |
| CoNS | 1 (0.9%) | 1 (1.1%) | 0 (0%) | 0% |
| Group A | 14 (12.1%) | 9 (9.9%) | 5 (20.8%) | 35.7% |
| Group B | 1 (0.9%) | 1 (1.1%) | 0 (0%) | 0% |
| Group D | 2 (1.7%) | 1 (1.1%) | 1 (4.2%) | 50% |
| Non-group ABD | 6 (5.2%) | 6 (6.6%) | 0 (0%) | 0% |
| α-Hemolysis | 4 (3.5%) | 3 (3.3%) | 1 (4.2%) | 25% |
| Enterococcus | 7 (6.1%) | 7 (7.7%) | 0 (0%) | 0% |
| 57 (49.6%) | 42 (46.2%) | 12 (50%) | 21.1% | |
| | 11 (9.6%) | 10 (11%) | 1 (4.2%) | 9.1% |
| | 7 (6.1%) | 5 (5.5%) | 2 (8.3%) | 28.6% |
| Enterobacter species | 4 (3.5%) | 4 (4.4%) | 0 (0%) | 0% |
| | 3 (2.6%) | 3 (3.3%) | 0 (0%) | 0% |
| | 3 (2.6%) | 2 (2.2%) | 1 (4.2%) | 33.3% |
| | 7 (6.1%) | 7 (7.7%) | 0 (0%) | 0% |
| | 7 (6.1%) | 2 (2.2%) | 5 (20.8%) | 71.4% |
| | 2 (1.7%) | 0 (0%) | 2 (8.3%) | 100% |
| | 1 (0.9%) | 1 (1.1%) | 0 (0%) | 0% |
| | 5 (4.3%) | 4 (4.4%) | 1 (4.2%) | 20% |
| | 1 (0.9%) | 1 (1.1%) | 0 (0%) | 0% |
| | 1 (0.9%) | 1 (1.1%) | 0 (0%) | 0% |
| | 2 (1.7%) | 2 (2.2%) | 0 (0%) | 0% |
| 3 (2.6%) | 2 (2.2%) | 1 (4.2%) | 33.3% | |
| | 1 (0.9%) | 1 (1.1%) | 0 (0%) | 0% |
| | 2 (1.7%) | 1 (1.1%) | 1 (4.2%) | 50% |
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; CoNS, coagulase negative Staphylococcus.
Summary of baseline characteristics by outcome.
| Survival ( | Death ( | ||
|---|---|---|---|
| | 54.0 (44.0, 68.0) | 61.0 (55.5, 71.5) | 0.046 |
| | 0.049 | ||
| Female | 24 (26.4) | 12 (50.0) | |
| Male | 67 (73.6) | 12 (50.0) | |
| | 23.0 (15.0, 35.0) | 11.5 (4.0, 25.5) | 0.001 |
| | 31 (34.1) | 14 (58.3) | 0.053 |
| | 25 (27.5) | 8 (33.3) | 0.756 |
| | 42 (46.2) | 12 (50.0) | 0.916 |
| | 20 (22.0) | 9 (37.5) | 0.196 |
| | 26 (28.6) | 12 (50.0) | 0.082 |
| | 6 (6.6) | 2 (8.3) | 0.672 |
| | 28 (30.8) | 14 (58.3) | 0.024 |
| | 16 (17.6) | 2 (8.3) | 0.356 |
| | 11.9 (9.5, 13.1) | 9.9 (8.6, 10.8) | 0.001 |
| | 13.9 (9.8, 22.2) | 14.2 (9.7, 21.3) | 0.682 |
| | 243.0 (146.0, 332.0) | 78.0 (48.0, 110.0) | <0.001 |
| | 12.0 (11.0, 12.9) | 14.5 (12.9, 16.6) | <0.001 |
| | 33.1 (29.8, 36.0) | 49.4 (39.4, 59.4) | <0.001 |
| | 120.0 (100.0, 174.0) | 280.0 (198.5, 382.0) | <0.001 |
| | 1.3 (0.9, 2.4) | 3.6 (2.5, 4.4) | <0.001 |
| | 35.0 (19.0, 53.0) | 130.5 (38.0, 161.5) | <0.001 |
| | 24.0 (14.0, 36.0) | 98.5 (20.0, 125.5) | <0.001 |
| | 2.8 (2.3, 3.1) | 1.7 (1.2, 2.0) | <0.001 |
HB, hemoglobin; WBC, white cell count; PLT, platelet; PT, prothrombin time; APTT, activated partial thromboplastin time; GLU, glucose; Cr, creatinine; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
The continuous data were presented as median (IQR), and compared between different groups by Mann–Whitney U test.
The categorical variables were expressed by counts and percentages, and compared between different groups by the Yate's continuity correction or the Fisher's exact test, as appropriate.
Indicated a significant difference between survival and death.
Univariate and multivariate logistic regression models for the event of death.
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| OR | (95% CI) | Adjusted OR | (95% CI) | |||
| Age (years) | 1.03 | (1.00, 1.07) | 0.060 | 1.04 | (0.99, 1.09) | 0.164 |
| Gender (male) | 0.36 | (0.14, 0.90) | 0.030 | 0.18 | (0.04, 0.86) | 0.032 |
| Hospital days (day) | 0.94 | (0.89, 0.98) | 0.003 | 0.91 | (0.85, 0.97) | 0.004 |
| Diabetes mellitus | 2.71 | (1.08, 6.80) | 0.034 | |||
| Hypertension | 1.32 | (0.50, 3.47) | 0.573 | |||
| Liver cirrhosis | 1.17 | (0.47, 2.87) | 0.737 | |||
| CV dis | 2.13 | (0.81, 5.58) | 0.124 | |||
| Chronic renal dis | 2.50 | (1.00, 6.28) | 0.051 | |||
| Malignancy | 1.29 | (0.24, 6.83) | 0.766 | |||
| Peptic ulcer disease | 3.15 | (1.25, 7.95) | 0.015 | |||
| Gout | 0.43 | (0.09, 2.00) | 0.279 | |||
| HB (g/dL) | 0.69 | (0.54, 0.86) | 0.001 | |||
| WBC (103/μL) | 0.98 | (0.93, 1.04) | 0.594 | |||
| PLT (103/μL) | 0.98 | (0.98, 0.99) | <0.001 | |||
| PT (s) | 1.31 | (1.11, 1.55) | 0.002 | |||
| APTT (s) | 1.23 | (1.13, 1.34) | <0.001 | |||
| GLU (mg/dL) | 1.01 | (1.00, 1.01) | <0.001 | |||
| Cr (mg/dL) | 3.24 | (2.00, 5.26) | <0.001 | |||
| AST (IU/L) | 1.03 | (1.02, 1.04) | <0.001 | |||
| ALT (IU/L) | 1.04 | (1.02, 1.06) | <0.001 | |||
| Albumin (g/dL) | 0.06 | (0.02, 0.19) | <0.001 | 0.05 | (0.01, 0.18) | <0.001 |
HB, hemoglobin; WBC, white cell count; PLT, platelet; PT, prothrombin time; APTT, activated partial thromboplastin time; GLU, glucose; Cr, creatinine; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TB, total bilirubin; DB, direct bilirubin.
Indicates a significant association with the event of death.
Summary of characteristics by outcome (survival or death) in necrotizing fasciitis patients with liver cirrhosis.
| Survival ( | Death ( | ||
|---|---|---|---|
| | 25 (59.5) | 8 (66.7) | 0.747 |
| | <0.001 | ||
| A and B | 34 (81.0) | 2 (16.7) | |
| C | 8 (19.0) | 10 (83.3) | |
| | 7 (16.7) | 2 (16.7) | 1.000 |
| | 13 (31.0) | 3 (25.0) | 1.000 |
The categorical variables were expressed by counts and percentages, and compared between different groups by the Fisher's exact test, as appropriate.
Indicated a significant difference between survival and death.